Allergic Disease & Asthma Center

Asthma Studies● A study on the effectiveness and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma that is inadequately controlled by standard of care. Learn more here (NCT04609878)● An observational study on the treatment patterns of adults with severe asthma. Learn more here (NCT03373045)● A study assessing the long-term effect of dupilumab on prevention of lung function decline in adult patients with uncontrolled moderate to severe asthma. Learn more here (NCT05097287)● Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States. Learn more here (NCT05329194)

Atopic Dermatitis Studies● An observational study in pediatric patients with moderate to severe atopic dermatitis that is not adequately controlled with topical prescription therapies or therapies that are medically advisable. Learn more here (NCT03687359)● A study evaluating biomarkers of atopic dermatitis in pediatric patients whose disease is not adequately controlled with topical prescription therapies or therapies that are medically advisable. Learn more here (NCT03849716)

Nasal Polyps Studies● A study assessing long-term outcomes of dupilumab (Dupixent®) treatment in adult patients with chronic rhinosinusitis (inflammation of the sinuses and nasal passages) with nasal polyposis. Learn more here (NCT04959448)

Disease Cough● A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough. Learn more here (NCT05660850)

Neil Kao, MDPrinciple Investigator

Emmanuel Sarmiento, MD
Investigator

Candace Cothran, PA-C
Investigator

Leigh T. Paxton PA-C
Investigator

Rebecca FairclothClinical Research Coordinator

Elissa PeeryClinical Research Coordinator

Seth RogersClinical Research Coordinator

WHAT IS A CLINICAL TRIAL?
Clinical trials are conducted in a healthcare setting (a hospital or clinic) and are typically monitored by a trained healthcare professional. An Institutional Review Board or IRB approves all clinical trials. This is a committee made up of doctors, ethicists, members of the general public and administrators. This group is held responsible for agreeing that a trial does not represent an unreasonable risk to patients who are participating. Trials are also reviewed by the FDA. Your doctor is responsible for your well-being and is the best person to decide whether or not you are eligible to participate in a trial.
WHAT ARE THE BENEFITS OF PARTICIPATING IN A CLINCAL TRIAL?
In many cases, research studies give patients opportunities to access medications that are not yet available over-the-counter or with a prescription.
Often times the information collected during the study can allow your doctor learn more about your specific disease state and how it affects you. This may help your doctor provide you with better care during and after your study participation.
There are some cases where clinical trial participants are not treated with new medications, such as during an observational clinical trial; however, many patients who participate in these trials derive satisfaction from knowing they play a part in the effort to reduce the suffering of other people.
ARE THERE ANY RISKS INVOLVED WITH PARTICIPATING IN A CLINICAL TRIAL?
Medication Safety: Clinical trials are conducted in phases to determine the safety and effectiveness of a product in careful steps that help minimize the risks presented to clinical trial participants. To learn more about the different phases of clinical trials, go to https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics#6.
For more information about the safety of the investigational products tested at our site, speak with one of our Investigators or Clinical Research Coordinators.
Data Privacy: Because all of your data will be stored using a subject ID number, rather than any of your personal information, the only people who can affiliate your study data with you are our research staff (see our About ADAC Research, PA section) and our site monitors (a site monitor is a representative working for the study sponsor who can review your study data while physically on-site at our Butler Road office, but who cannot leave our site with any of your personal identifying information).
Time Commitment: Research study visits are often longer and scheduled more frequently than routine doctors’ visits, so they can require more time commitment; however, all assessments completed during these visits are performed at no monetary cost to you. In addition, these assessments can help the study doctor better understand your specific symptoms which may help them provide you with better care.
HOW WILL I KNOW IF I AM ELIGIBLE FOR A CLINICAL TRIAL?
Talk to your doctor and/or contact our research department to find out if a trial is right for you.
WHAT WILL PARTICIPATING IN A CLINICAL TRIAL REQUIRE OF ME?
A patient’s involvement in a clinical trial will vary based on the study. For this reason, every clinical trial is required to provide patients with an informed consent form that they must sign prior to their study participation. An informed consent form explains a patient’s role in a research study and outlines exactly what is expected of the patient during their participation in the trial. It also outlines potential side effects of the medication being tested (if applicable), potential risks and benefits of the specific study, whether or not the patient is compensated for their participation, and more.

If you have any questions, feel free to contact us using the information below or fill out the contact form.

Address

1202 E Butler Rd, Greenville, SC 29607

Contacts

P. (864) 627-3800, Ext 221 or 223F. (864) 672-2654, Attn: Researchmoc.esaesidcigrella%40hcraeser

1202 E Butler Rd, Greenville,SC 29607
P. (864) 627-3800
F. (864) 672-2654
moc.esaesidcigrella%40ofni

Quick Links

Pollen Count Information